Back

Clinical update on BET inhibition: the patient profile that may benefit from BET inhibition?

31 August 2019 (16:05 - 16:20)
Organised by:
Congress Presentation Part of: Epigenetics: a new pathway to tackle residual risk? Treatment ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Introduction
Professor U. Landmesser (Berlin, DE)
Slides Video
Presentation thumbnail
Challenges in targeting residual risk in diabetic patients, post ACS
Professor P. Libby (Boston, US)
Slides Video
Presentation thumbnail
BET inhibition, an epigenetic pathway: how could BET inhibition modulate atherothrombotic risk
Professor J. Jukema (Leiden, NL)
Slides Video
Presentation thumbnail
Discussion
Professor U. Landmesser (Berlin, DE) Professor K. Ray (London, GB)
Slides Video

Access the full session

Session thumbnail
Epigenetics: a new pathway to tackle residual risk?

The Event

Event poster

ESC Congress 2019

31 August 2019 16:05 CET